Ibalizumab (CD4 D3 domain) - Research Grade Biosimilar, Unconjugated, Monoclonal

Artikelnummer: PRS-10-262
Artikelname: Ibalizumab (CD4 D3 domain) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer: PRS-10-262
Hersteller Artikelnummer: 10-262
Alternativnummer: PRS-10-262-0.1
Hersteller: ProSci
Kategorie: Antikörper
Immunogen: Humanized / CD4 D3 domain [Homo sapiens]
Konjugation: Unconjugated
Alternative Synonym: Hu5A8,TMB-355,TNX-355
Klonalität: Monoclonal
Konzentration: batch dependent
Puffer: PBS buffer pH7.5
Quelle: CHO cells
Application Verdünnung: Optimal dilutions for each application to be determined by the researcher.